Suppr超能文献

肝硬化门静脉高压症合并症状性胆石症患者行胆囊切开取石术联合亮菌甲素与胆囊切除术的比较

Cholecystolithotomy Combined Armillarisin A versus Cholecystectomy in Cirrhotic Portal Hypertension Patients with Symptomatic Cholelithiasis.

作者信息

Fei Yang, Li Wei-Qin, Zong Guang-Quan, Chen Jian, Wang Wei

出版信息

Chirurgia (Bucur). 2017 Mar-Apr;112(2):143-151. doi: 10.21614/chirurgia.112.2.143.

Abstract

OBJECT

To discover whether cirrhotic portal hypertension patients with symptomatic cholelithiasis would benefit from cholecystolithotomy combined with Armillarisin A in the authors hospital. Sixty-one patients with cirrhotic portal hypertension and symptomatic gallstone disease who underwent either cholecystolithotomy combined with Armillarisin A (group A) or cholecystectomy (group B) for cholelithiasis from Feb 2007 to March 2011 were retrospectively reviewed. These patients were undergoing simultaneous procedure for esophageal varices. The operation-relevant information, change of laboratory examination data, postoperative complications and symptoms were analyzed. There were no significant differences between group A and group B in mean operative time, intraoperative blood loss, time to resume diet postoperatively and length of hospital stay (P 0.05). The hepatic function biochemical profile and Child-Pugh'™s score at 2 weeks and 1 month after operations were both altered significantly less in group A than in group B (ALT, 0.008, 0.011; AST, 0.006, 0.003; Child-Pugh'™s score, 0.010, 0.016, respectively). However, at 6 months postoperatively, the changes were not significant (P 0.05). Except for gallstone recurrence and wound infection, occurrences or development of postoperative complications including biliary fistula, liver failure and subphrenic infection showed significant differences between the two groups (P = 0.037, P = 0.041, P = 0.019, respectively). After a mean follow-up of 4.2 years, all patients remain alive. Twenty-seven patients in group A (93%) are free of biliary symptoms.

CONCLUSION

Cholecystolithotomy combined with using Armillarisin A is a useful treatment for symptomatic gallstones in patients with cirrhotic portal hypertension who are at high risk for cholecystectomy. It preserves gallbladder function and reduces the possibility of liver failure; moreover the rate of recurrent gallstones are relatively low.

摘要

目的

探讨在作者所在医院,有症状性胆石症的肝硬化门静脉高压患者行胆囊取石术联合亮菌甲素治疗是否有益。回顾性分析2007年2月至2011年3月期间,61例因胆石症接受胆囊取石术联合亮菌甲素治疗(A组)或胆囊切除术(B组)的肝硬化门静脉高压合并症状性胆石病患者。这些患者同时接受了食管静脉曲张手术。分析了手术相关信息、实验室检查数据变化、术后并发症及症状。A组和B组在平均手术时间、术中出血量、术后恢复饮食时间和住院时间方面无显著差异(P>0.05)。A组术后2周和1个月时肝功能生化指标及Child-Pugh评分的改变均明显小于B组(ALT,P=0.008,P=0.011;AST,P=0.006,P=0.003;Child-Pugh评分,P=0.010,P=0.016)。然而,术后6个月时,差异无统计学意义(P>0.05)。除胆石复发和伤口感染外,两组术后并发症包括胆瘘、肝衰竭和膈下感染的发生或发展存在显著差异(分别为P=0.037, P=0.041, P=0.019)。平均随访4.2年后,所有患者均存活。A组27例患者(93%)无胆系症状。

结论

胆囊取石术联合亮菌甲素对胆囊切除术高风险的肝硬化门静脉高压有症状性胆石症患者是一种有效的治疗方法。它保留了胆囊功能,降低了肝衰竭的可能性;此外,胆石复发率相对较低。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验